


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:03:37Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406976" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406976</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ejneurol</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="ene70338" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">4612</journal-id><journal-id journal-id-type="pmc-domain">ejneurol</journal-id><journal-id journal-id-type="publisher-id">ENE</journal-id><journal-title-group><journal-title>European Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">1351-5101</issn><issn pub-type="epub">1468-1331</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406976</article-id><article-id pub-id-type="pmcid-ver">PMC12406976.1</article-id><article-id pub-id-type="pmcaid">12406976</article-id><article-id pub-id-type="pmcaiid">12406976</article-id><article-id pub-id-type="pmid">40900604</article-id><article-id pub-id-type="doi">10.1111/ene.70338</article-id><article-id pub-id-type="publisher-id">ENE70338</article-id><article-id pub-id-type="other">EJoN-25-1425</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Functional Neurological Disorder Among Neurology In&#8208;Patients</article-title></title-group><contrib-group><contrib id="ene70338-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Jungilligens</surname><given-names initials="J">Johannes</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4846-8337</contrib-id><xref rid="ene70338-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>johannes.jungilligens@rub.de</email></address></contrib><contrib id="ene70338-cr-0002" contrib-type="author"><name name-style="western"><surname>Marcinkowski</surname><given-names initials="E">Emma</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-4360-0852</contrib-id><xref rid="ene70338-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ene70338-cr-0003" contrib-type="author"><name name-style="western"><surname>Wehner</surname><given-names initials="T">Tim</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3319-2339</contrib-id><xref rid="ene70338-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ene70338-note-0001" ref-type="author-notes">
<sup>[Link]</sup>
</xref></contrib><contrib id="ene70338-cr-0004" contrib-type="author"><name name-style="western"><surname>Skodda</surname><given-names initials="S">Sabine</given-names></name><xref rid="ene70338-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ene70338-cr-0005" contrib-type="author"><name name-style="western"><surname>Popkirov</surname><given-names initials="S">Stoyan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6168-0036</contrib-id><xref rid="ene70338-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70338-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="ene70338-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Knappschaft Kliniken University Hospital Bochum, Ruhr University Bochum</institution>
<city>Bochum</city>
<country country="DE">Germany</country>
</aff><aff id="ene70338-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Ruhr Epileptology, Department of Neurology</named-content>
<institution>Knappschaft Kliniken University Hospital Bochum, Ruhr University Bochum</institution>
<city>Bochum</city>
<country country="DE">Germany</country>
</aff><aff id="ene70338-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology and Center for Translational Neuro&#8208; and Behavioral Sciences (C&#8208;TNBS)</named-content>
<institution>University Hospital Essen, University Duisburg&#8208;Essen</institution>
<city>Essen</city>
<country country="DE">Germany</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><break/>
Johannes Jungilligens (<email>johannes.jungilligens@rub.de</email>)<break/></corresp><fn fn-type="funding" id="ene70338-note-0001"><p>
<bold>Funding:</bold> S.P. is supported by a BMBF Advanced Clinician Scientist Programme UMEA<sup>2</sup> (01EO2104).</p></fn></author-notes><pub-date pub-type="epub"><day>03</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>32</volume><issue seq="12">9</issue><issue-id pub-id-type="pmc-issue-id">495814</issue-id><issue-id pub-id-type="doi">10.1111/ene.v32.9</issue-id><elocation-id>e70338</elocation-id><history><date date-type="rev-recd"><day>08</day><month>8</month><year>2025</year></date><date date-type="received"><day>28</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>16</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">European Journal of Neurology</italic> published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="ENE-32-e70338.pdf"/><self-uri content-type="pdf" xlink:href="file:ENE-32-e70338.pdf"/><abstract><title>ABSTRACT</title><sec id="ene70338-sec-0001"><title>Background</title><p>The high prevalence of functional neurological disorders (FND) in specialized neurological services such as epilepsy centers or dizziness clinics is well established. Few studies exist that investigate the frequency of FND among neurology in&#8208;patients.</p></sec><sec id="ene70338-sec-0002"><title>Methods</title><p>In&#8208;hospital patients with functional neurological symptoms as part of the presenting complaint were identified by combining prospective and retrospective case ascertainment over a period of 2&#8201;years. Demographic and clinical features as well as reimbursements were analyzed.</p></sec><sec id="ene70338-sec-0003"><title>Results</title><p>Across a total of 4648 in&#8208;hospital patients, 267 (5.7%) had functional neurological symptoms as a presenting complaint, and 217 (4.7%) were given a standalone FND diagnosis. All age groups and subtypes of FND were represented. FND comprised 2.4% of all cases admitted to the stroke unit for suspected stroke; 11.8% of all cases undergoing specialized epileptological workup; and 7.6% of cases admitted through the emergency department with a seizure disorder. Diagnostic coding of FND was inconsistent and associated with significantly lower per&#8208;day revenue when performed accurately.</p></sec><sec id="ene70338-sec-0004"><title>Conclusions</title><p>FND is the third most common diagnosis among in&#8208;hospital neurological patients, which stands in stark contrast to its underrepresentation in clinical training, service provision, and research funding. Stroke&#8208;like presentations and seizures are common forms of FND among emergency admissions. Reimbursement mechanisms of the diagnosis&#8208;related groups system might disincentivize accurate diagnostic coding and contribute to a cycle of neglect within health care.</p></sec></abstract><abstract abstract-type="graphical"><p>Functional neurological disorder (FND) was the third most&#8208;common diagnosis across a total of 4648 consecutive in&#8208;hospital neurology patients. In patients with functional neurological symptoms as the leading complaint, diagnostic coding of FND was inconsistent, with 28% receiving a non&#8208;functional primary diagnosis. Diagnostic coding as FND was associated with significantly lower per&#8208;day revenue when performed accurately; potentially contributing to a cycle of under&#8208;recognition and misdiagnosis.<boxed-text position="anchor" content-type="graphic" id="ene70338-blkfxd-0001" orientation="portrait"><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="ENE-32-e70338-g004.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ene70338-kwd-0001">costs</kwd><kwd id="ene70338-kwd-0002">dissociative seizures</kwd><kwd id="ene70338-kwd-0003">FND</kwd><kwd id="ene70338-kwd-0004">functional neurological disorder</kwd><kwd id="ene70338-kwd-0005">functional seizures</kwd><kwd id="ene70338-kwd-0006">stroke mimics</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Bundesministerium f&#252;r Bildung und Forschung</institution><institution-id institution-id-type="doi">10.13039/501100002347</institution-id></institution-wrap></funding-source><award-id>01EO2104</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="2"/><page-count count="7"/><word-count count="4000"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:03.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="ene70338-cit-1001"><string-name name-style="western"><given-names>J.</given-names><surname>Jungilligens</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Marcinkowski</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Wehner</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Skodda</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Popkirov</surname></string-name>, &#8220;<article-title>Functional Neurological Disorder Among Neurology In&#8208;Patients</article-title>,&#8221; <source>European Journal of Neurology</source><volume>32</volume>, no. <issue>9</issue> (<year>2025</year>): <elocation-id>e70338</elocation-id>, <pub-id pub-id-type="doi">10.1111/ene.70338</pub-id>.<pub-id pub-id-type="pmid">40900604</pub-id><pub-id pub-id-type="pmcid">PMC12406976</pub-id></mixed-citation>
</p></notes></front><body id="ene70338-body-0001"><sec id="ene70338-sec-0005"><label>1</label><title>Introduction</title><p>Functional neurological disorders (FNDs) are impairments of behavioral control and perception that arise primarily from aberrant neural processing and higher&#8208;order psychological processes rather than structural alterations of the nervous system. They comprise a diverse set of symptoms, from convulsions to paralysis and many kinds of sensory disruptions. Despite this variety of presentations and justified subgroup distinctions, they share common pathophysiological mechanisms, diagnostic principles, and therapeutic approaches [<xref rid="ene70338-bib-0001" ref-type="bibr">1</xref>, <xref rid="ene70338-bib-0002" ref-type="bibr">2</xref>]. Although distinct subtypes of FND such as functional seizures, stroke&#8208;like presentations, or functional dizziness require focused research, a broader view on FND is also warranted.</p><p>The prevalence of FND has been conservatively estimated at 80&#8211;140/100000, far surpassing that of other common neurological conditions such as multiple sclerosis [<xref rid="ene70338-bib-0003" ref-type="bibr">3</xref>]. This is reflected in studies from general neurological outpatient clinics, where functional disorders account for about one in six new presentations [<xref rid="ene70338-bib-0004" ref-type="bibr">4</xref>, <xref rid="ene70338-bib-0005" ref-type="bibr">5</xref>]. Studies investigating the frequency of FND among in&#8208;patients in neurology departments of general hospitals are rare. An older retrospective analysis of 4470 consecutive in&#8208;patients treated between 1985 and 1987 at an academic neurology department in Germany found that FND accounts for 9% of all cases&#160;[<xref rid="ene70338-bib-0006" ref-type="bibr">6</xref>]. A more recent study from Italy (2021&#8211;2022) found a rate of 4.4% among 843 consecutive patients [<xref rid="ene70338-bib-0007" ref-type="bibr">7</xref>]. This constitutes a remarkable proportion of all neurological in&#8208;hospital patients and deserves more attention from all stakeholders than it currently does [<xref rid="ene70338-bib-0008" ref-type="bibr">8</xref>, <xref rid="ene70338-bib-0009" ref-type="bibr">9</xref>]. FND is a notoriously neglected and underserved area of neurology, and bringing clarity to its relative frequency and clinical characteristics within hospital care is an important step towards improving care.</p><p>Large&#8208;scale epidemiological studies often rely on coding of discharge diagnosis and thus entail the risk for underreporting. Studies have repeatedly shown that cases of clinically diagnosed FND are often not documented or coded as such [<xref rid="ene70338-bib-0010" ref-type="bibr">10</xref>, <xref rid="ene70338-bib-0011" ref-type="bibr">11</xref>, <xref rid="ene70338-bib-0012" ref-type="bibr">12</xref>, <xref rid="ene70338-bib-0013" ref-type="bibr">13</xref>]. For this reason, studies based solely on decontextualized insurance or hospital coding data can introduce significant biases in reporting. Prospective screening across entire institutions, in contrast, is logistically challenging for long study periods and large sample sizes.</p><p>Here, we investigate the frequency of FND in in&#8208;hospital care over a 2&#8208;year period employing a dual prospective and retrospective case identification strategy. The cohort is then characterized from various perspectives to reveal clinically, scientifically, and economically salient features.</p></sec><sec sec-type="methods" id="ene70338-sec-0006"><label>2</label><title>Methods</title><sec id="ene70338-sec-0007"><label>2.1</label><title>Study Setting</title><p>This study investigates the frequency, treatment pathways, and associated costs of cases with functional neurological symptoms among in&#8208;patients of a department of neurology at a German university hospital (Knappschaft Kliniken University Hospital Bochum). The department is a representative mid&#8208;sized neurology unit, featuring a specialized epilepsy center and a supraregional stroke unit that provides round&#8208;the&#8208;clock thrombectomy services. Other treatment specializations are neuro&#8208;oncology and movement disorders. The department has no rehabilitation program; elective admissions (about a third of total inpatient volume) are primarily for diagnostic assessment or acute treatment. The study received approval by the ethics&#160;committee of the medical faculty, Ruhr University Bochum (reg.&#8208;no.: 20&#8208;7038_1&#8208;BR).</p></sec><sec id="ene70338-sec-0008"><label>2.2</label><title>Case Data Inclusion</title><p>During a period of 2&#8201;years (July 30, 2020 to July 30, 2022), cases of neurology in&#8208;patients with functional neurological symptoms as primary or secondary diagnoses were prospectively identified during the final coding of the case files for hospital accounting after discharge. Additionally, medical records of all patients discharged from neurology in this time period were retrospectively screened using ICD&#8208;10 codes to identify cases that were erroneously missed in the prospective screening. This two&#8208;pronged approach was chosen, since functional disorders in neurology are oftentimes coded inconsistently [<xref rid="ene70338-bib-0010" ref-type="bibr">10</xref>, <xref rid="ene70338-bib-0011" ref-type="bibr">11</xref>, <xref rid="ene70338-bib-0012" ref-type="bibr">12</xref>, <xref rid="ene70338-bib-0013" ref-type="bibr">13</xref>]. In total, 267 cases of in&#8208;patients with functional neurological symptoms were identified (241 prospectively with 26 additional cases retrospectively). The list of all inpatient cases treated in the department of neurology additionally included 4381 cases without functional neurological symptoms. Thus, a total of 4648 cases were included in the analyses. Patients treated at other departments that received neurological consults were not included.</p><p>Detailed individual case data was obtained both through in&#8208;depth review of the discharge letters of in&#8208;patients with functional neurological symptoms (Table&#160;<xref rid="ene70338-supitem-0001" ref-type="supplementary-material">S1</xref>) and through automated data retrieval from the department of medical billing and controlling (duration of stay, revenue per day, procedures and treatments, whether the functional symptom was coded as primary diagnosis) for all cases. In the German healthcare system, hospitals are reimbursed for inpatient care through the diagnosis related groups system: For each patient case, a code is assigned based on the primary diagnosis, comorbidities, and illness severity. The code is related to a fixed reimbursement amount, modified to a degree by length of stay and by some procedures, although generally not by non&#8208;invasive diagnostic procedures. Here, we used the total revenue generated by each case divided by the duration of stay to compare cases on a revenue&#8208;per&#8208;day basis.</p></sec><sec id="ene70338-sec-0009"><label>2.3</label><title>Statistics</title><p>All analyses were performed using jamovi running R version 4.4 [<xref rid="ene70338-bib-0014" ref-type="bibr">14</xref>, <xref rid="ene70338-bib-0015" ref-type="bibr">15</xref>]. Most analyses rely on displaying frequencies, with some additionally comparing frequencies between groups using Fisher's exact test with Monte Carlo simulation or Chi&#8208;Square tests. Additionally, Mann&#8211;Whitney <italic toggle="yes">U</italic> tests were used to compare data between groups.</p></sec></sec><sec sec-type="results" id="ene70338-sec-0010"><label>3</label><title>Results</title><sec id="ene70338-sec-0011"><label>3.1</label><title>Patient Characteristics</title><p>Of the 4648 inpatient cases treated at the department of neurology in the 2&#8208;year timeframe, 267 (5.7%) presented with suspected or confirmed functional neurological symptoms as part of their main complaint. In 217 cases (4.7%), clinically confirmed or suspected FND was given as a final standalone diagnosis (Figure&#160;<xref rid="ene70338-fig-0001" ref-type="fig">1</xref>). In the remaining cases, symptoms were part of another neurological or psychiatric disorder (i.e., functional component, <italic toggle="yes">n</italic>&#8201;=&#8201;41), or did not reach diagnostic threshold for suspected FND (i.e., medically unexplained neurological symptoms, <italic toggle="yes">n</italic>&#8201;=&#8201;9). At 4.7%, FND was the third most common diagnostic group (after stroke/transient ischemic attack with 29% and epilepsy with 14.8% of cases), more common than Parkinson's Disease or Multiple Sclerosis (Table&#160;<xref rid="ene70338-tbl-0001" ref-type="table">1</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70338-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Relative frequencies of diagnoses across 4648 consecutive in&#8208;patients at the department of neurology in the 2&#8208;year timeframe. Functional neurological disorder cases are based on clinical data; all other diagnoses are based on ICD&#8208;10 diagnostic codes.</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="ENE-32-e70338-g005.jpg"/></fig><table-wrap position="float" id="ene70338-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Common diagnostic groups among 4648 consecutive in&#8208;patients.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Disorder</th><th align="center" valign="bottom" rowspan="1" colspan="1">ICD&#8208;10 code</th><th align="center" valign="bottom" rowspan="1" colspan="1">Percent</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Stroke and transient ischemic attack</td><td align="center" valign="top" rowspan="1" colspan="1">I63/G45</td><td align="center" valign="top" rowspan="1" colspan="1">29.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Epilepsy</td><td align="center" valign="top" rowspan="1" colspan="1">G40</td><td align="center" valign="top" rowspan="1" colspan="1">14.8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Functional neurological disorder (clinical diagnosis)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>n/a</bold>
<xref rid="ene70338-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>4.7%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional neurological disorder (code&#8208;based)</td><td align="center" valign="top" rowspan="1" colspan="1">F44/F45<xref rid="ene70338-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">3.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Parkinson's disease</td><td align="center" valign="top" rowspan="1" colspan="1">G20</td><td align="center" valign="top" rowspan="1" colspan="1">3.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non&#8208;follicular lymphoma</td><td align="center" valign="top" rowspan="1" colspan="1">C83</td><td align="center" valign="top" rowspan="1" colspan="1">3.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Other cerebrovascular disorder</td><td align="center" valign="top" rowspan="1" colspan="1">I67</td><td align="center" valign="top" rowspan="1" colspan="1">2.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Headache</td><td align="center" valign="top" rowspan="1" colspan="1">R51</td><td align="center" valign="top" rowspan="1" colspan="1">1.9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Multiple sclerosis</td><td align="center" valign="top" rowspan="1" colspan="1">G35</td><td align="center" valign="top" rowspan="1" colspan="1">1.9%</td></tr></tbody></table><table-wrap-foot id="ene70338-ntgp-0002"><fn id="ene70338-note-0002"><p>
<italic toggle="yes">Note:</italic> Incomplete listing of diagnostic groups. The department of neurology at the Knappschaft Kliniken University Hospital Bochum features a supraregional stroke unit and an epilepsy monitoring unit. It also has a particular treatment focus on primary central nervous system lymphoma.</p></fn><fn id="ene70338-note-0003"><label>
<sup>a</sup>
</label><p>Since ICD&#8208;10 diagnostic coding for functional disorders is known to be inconsistent, we include the number of cases according to our case definition (based on discharge summary review) in addition to the ICD&#8208;10&#8208;based grouping.</p></fn><fn id="ene70338-note-0004"><label>
<sup>b</sup>
</label><p>Excluding F45.4, which is used for primary chronic pain disorders only.</p></fn></table-wrap-foot></table-wrap><p>Nine patients were admitted twice within the study period (one of whom was admitted a third time). The median time between admissions was about 6&#8201;months (range: 24&#8211;500&#8201;days). Six of those cases were patients with functional seizures.</p><p>While 19% of patients with functional neurological symptoms presented with mixed symptoms, the most common leading symptoms were functional seizures (35.6%), followed by functional movement disorders (24%), functional sensory symptoms (13.5%), functional limb weakness (10.9%), functional cognitive symptoms (7.9%), functional dizziness (3.7%), other functional symptoms (3.4%), and fatigue (1.5%).</p><p>Of the 267 cases with functional neurological symptoms, 66.7% (178) were female and 33.3% (89) were male; this female predominance was reflected across all subtypes, except for functional limb weakness, which had an equal ratio of male and female patients (Figure&#160;<xref rid="ene70338-fig-0002" ref-type="fig">2</xref>). Functional symptoms were seen across all ages, with a peak around middle age (Figure&#160;<xref rid="ene70338-fig-0003" ref-type="fig">3</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70338-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Gender distribution across functional symptom domains.</p></caption><graphic position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="ENE-32-e70338-g001.jpg"/></fig><fig position="float" fig-type="FIGURE" id="ene70338-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Gender distribution across age groups.</p></caption><graphic position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="ENE-32-e70338-g006.jpg"/></fig><p>A Fisher's exact test with Monte Carlo simulation found a significant association between age groups and the domain of the leading functional symptom (Monte Carlo simulated significance <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; 99% confidence interval [&lt;&#8201;0.001, &lt;&#8201;0.001]): functional seizures were most common in the youngest age group (15&#8211;29&#8201;years), while functional cognitive symptoms were most common in the middle age (45&#8211;59&#8201;years). Functional movement disorders were equally distributed across age groups (Figure&#160;<xref rid="ene70338-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70338-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Functional neurological symptom domains across age groups.</p></caption><graphic position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="ENE-32-e70338-g003.jpg"/></fig></sec><sec id="ene70338-sec-0012"><label>3.2</label><title>Treatment and Associated Costs</title><p>Next, we focused on patients with clinically confirmed or suspected FND (<italic toggle="yes">n</italic>&#8201;=&#8201;217), excluding patients with functional neurological symptoms in the context of other diagnoses.</p><p>In 69% of cases, symptoms were chronic (persisting for more than 1&#8201;month), while 31% presented with acute complaints (less than a month). Among those with chronic symptoms, most (59%) were admitted electively, whereas in those with acute symptoms, most (77%) were admitted as emergency cases.</p><p>The emergency admissions rate across all FND cases was lower than for in&#8208;patients without functional symptoms (49% vs. 59%); conversely, elective admissions accounted for about half of all FND cases, while in the sample of cases without FND this only applies to every third case (<italic toggle="yes">&#967;</italic>
<sup>2</sup>(3)&#8201;=&#8201;25.0; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><p>Cases with FND remained in the hospital for a median of 4&#8201;days (range: 1&#8211;31&#8201;days, interquartile range 2&#8211;7&#8201;days). A Mann&#8211;Whitney <italic toggle="yes">U</italic> test (<italic toggle="yes">Z</italic>&#8201;=&#8201;402,656; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) showed that this was significantly shorter than for cases with non&#8208;functional diagnoses (median 5&#8201;days, range 1&#8211;161&#8201;days, interquartile range 2&#8211;9&#8201;days).</p><p>The median total revenue per day was 595 &#8364;/day for FND cases (range 187&#8211;1330 &#8364;; inter quartile range 230&#8211;884 &#8364;) and 767 &#8364;/day for cases without FND (range 122&#8211;5681 &#8364;; inter quartile range 509&#8211;1077 &#8364;). This represents a significantly lower median total revenue per day for FND cases (Mann&#8211;Whitney&#8208;<italic toggle="yes">U</italic> test: <italic toggle="yes">Z</italic>&#8201;=&#8201;326,626; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; effect size rank&#8208;biserial correlation&#8201;=&#8201;0.310, Figure&#160;<xref rid="ene70338-fig-0005" ref-type="fig">5</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70338-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Distribution of the revenue per day for cases with functional neurological disorder (FND) compared to those without FND.</p></caption><graphic position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="ENE-32-e70338-g002.jpg"/></fig><p>In those with clinically confirmed or suspected FND, the functional disorder was coded as the primary diagnosis in 72%, while in the other 28%, a non&#8208;functional primary diagnosis was given, and the functional symptoms were coded as secondary diagnoses. There was a significant difference in the mean total revenue per day between these two groups (<italic toggle="yes">t</italic>&#8208;test: <italic toggle="yes">t</italic>(214)&#8201;=&#8201;2.68; <italic toggle="yes">p</italic>&#8201;=&#8201;0.008; effect size Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.409), with daily revenue for cases with FND as a primary diagnosis 19% lower than for those for whom functional symptoms were coded as secondary diagnoses (563 &#8364; vs. 692 &#8364;). Unlike between cases with clinically confirmed or suspected diagnoses of FND and cases with non&#8208;functional diagnoses, there was no difference in the average length of hospital stay (<italic toggle="yes">p</italic>&#8201;=&#8201;0.787). Furthermore, among those with a clinically confirmed or suspected standalone FND diagnosis, those with an F44 or F45 primary diagnosis (<italic toggle="yes">n</italic>&#8201;=&#8201;150; 69%) had a 16% lower mean daily revenue than those with alternative coding: 565 &#8364; versus 672 &#8364; (<italic toggle="yes">t</italic>&#8208;test: <italic toggle="yes">t</italic>(214)&#8201;=&#8201;2.27; <italic toggle="yes">p</italic>&#8201;=&#8201;0.024; effect size Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.334). Median length of stay was 4&#8201;days in both groups (<italic toggle="yes">p</italic>&#8201;=&#8201;0.834).</p><p>Overall, the most common examinations were cranial computed tomography (34% of patients), routine EEG (33% of patients), and brain MRI (32% of patients). The most common examinations were different between the different groups of leading functional symptom domains (see Table&#160;<xref rid="ene70338-tbl-0002" ref-type="table">2</xref> for details).</p><table-wrap position="float" id="ene70338-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Most commonly performed examinations per major functional symptom group.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Leading functional symptom</th><th align="center" valign="bottom" rowspan="1" colspan="1">Most performed examination</th><th align="center" valign="bottom" rowspan="1" colspan="1">Second most performed examination</th><th align="center" valign="bottom" rowspan="1" colspan="1">Third most performed examination</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">All</td><td align="center" valign="top" rowspan="1" colspan="1">CT brain (34%)</td><td align="center" valign="top" rowspan="1" colspan="1">Routine EEG (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">MRI brain (32%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional seizures</td><td align="center" valign="top" rowspan="1" colspan="1">Video&#8208;EEG (63%)</td><td align="center" valign="top" rowspan="1" colspan="1">Routine EEG (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">Supportive therapy of at least 50&#8201;min (37%)<xref rid="ene70338-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional limb weakness</td><td align="center" valign="top" rowspan="1" colspan="1">CT brain (59%)</td><td align="center" valign="top" rowspan="1" colspan="1">MRI brain (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">Cardiovascular monitoring (38%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional motor symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">CT brain (39%)</td><td align="center" valign="top" rowspan="1" colspan="1">Psychosomatic and psychotherapeutic evaluation (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">Somatosensory evoked potentials (25%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional sensory symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">CT brain (45%)</td><td align="center" valign="top" rowspan="1" colspan="1">MRI brain (34%)</td><td align="center" valign="top" rowspan="1" colspan="1">Diagnostic lumbar puncture (31%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional dizziness</td><td align="center" valign="top" rowspan="1" colspan="1">CT brain (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">MRI brain (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">Acoustically evoked potentials (30%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functional cognitive symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">Comprehensive neuropsychology (75%)</td><td align="center" valign="top" rowspan="1" colspan="1">MRI brain (35%)</td><td align="center" valign="top" rowspan="1" colspan="1">Psychosomatic/psychotherapeutic evaluation (30%)</td></tr></tbody></table><table-wrap-foot id="ene70338-ntgp-0003"><fn id="ene70338-note-0005"><p>
<italic toggle="yes">Note:</italic> CT, computed tomography; EEG, electroencephalography; MRI, magnetic resonance imaging.</p></fn><fn id="ene70338-note-0006"><label>
<sup>a</sup>
</label><p>Part of psychosocial support at the epileptology department, delivered by psychotherapist.</p></fn></table-wrap-foot></table-wrap></sec><sec id="ene70338-sec-0013"><label>3.3</label><title>Special Consideration: Functional Seizures</title><p>Our department of neurology houses a level 4 epilepsy center with a supra&#8208;regional outreach; thus, seizure patients might be over&#8208;represented in our sample compared to other hospitals. In the 2&#8208;year timeframe, 812 patients received a specialized epileptological diagnostic workup; 7.9% (64 cases) of those were patients with functional seizures, with 31 additional cases that were diagnosed with functional seizures but did not receive a specialized epileptological diagnostic workup. In sum, 11.8% of the overall epileptological workload was due to functional seizures. Among the 444 seizure patients admitted as emergency cases, 7.6% were discharged with a diagnosis of functional seizures. In 51 cases, patients were treated for status epilepticus, with five of those (9.8%) later diagnosed as functional seizures.</p></sec><sec id="ene70338-sec-0014"><label>3.4</label><title>Special Consideration: Stroke</title><p>Our hospital features a supra&#8208;regional stroke unit (1105 stroke cases treated in the 2&#8208;year timeframe). Functional stroke mimics (defined as cases that were admitted under the suspicion of a stroke) were seen in 38 cases, which represent 3.4% of all stroke patients. Of these, 27 cases (2.4% of all 1105 stroke cases) were treated in the stroke unit. Two patients with functional stroke mimics received thrombolysis due to initial misdiagnosis.</p></sec></sec><sec sec-type="discussion" id="ene70338-sec-0015"><label>4</label><title>Discussion</title><p>Our study found that among 4648 consecutive neurological in&#8208;patients over a 2&#8208;year period, 5.7% had functional neurological symptoms as a presenting complaint, most of whom (4.7% of total) were specifically diagnosed as having FND. This proportion is about half of what Lempert et&#160;al. found using similar methodology and sample size in Germany 35&#8201;years prior [<xref rid="ene70338-bib-0006" ref-type="bibr">6</xref>] and very close to the 4.4% recently reported by Pilotto et&#160;al. in Italy [<xref rid="ene70338-bib-0007" ref-type="bibr">7</xref>] This number is remarkable when contrasted with the minimal attention the topic of FND receives in neurology training, service provision, and research funding [<xref rid="ene70338-bib-0008" ref-type="bibr">8</xref>, <xref rid="ene70338-bib-0009" ref-type="bibr">9</xref>].</p><p>FND accounted for 2.4% of cases admitted to the stroke unit for suspected stroke. This is lower than the 8% reported from the UK and Qatar [<xref rid="ene70338-bib-0016" ref-type="bibr">16</xref>, <xref rid="ene70338-bib-0017" ref-type="bibr">17</xref>] likely due to national differences in treatment service organization (pre&#8208;hospital triage by emergency physician and neurology&#8208;led in&#8208;hospital emergency workup in Germany). Still, this confirms FND's position as an important differential diagnosis in the emergency work&#8208;up of suspected stroke [<xref rid="ene70338-bib-0018" ref-type="bibr">18</xref>] highlighted further by the fact that two of those patients (7%) received thrombolysis.</p><p>The importance of considering, recognizing, and treating functional seizures in the context of both acute neurology care and in epilepsy monitoring units is well established [<xref rid="ene70338-bib-0019" ref-type="bibr">19</xref>, <xref rid="ene70338-bib-0020" ref-type="bibr">20</xref>]. In our study, 11.8% of all cases undergoing specialized epileptological workup were discharged with a primary diagnosis of functional seizures, similar to the 18% reported recently by another German epilepsy center [<xref rid="ene70338-bib-0021" ref-type="bibr">21</xref>]. Interestingly, functional seizures also accounted for 7.6% of all cases admitted through the emergency department for a seizure disorder, which is on the lower end of previously reported rates [<xref rid="ene70338-bib-0022" ref-type="bibr">22</xref>, <xref rid="ene70338-bib-0023" ref-type="bibr">23</xref>]. This is likely explained by our methodology based on discharge diagnoses, whereby reasons for emergency admissions other than acute seizures (e.g., medication side effects or subacute changes in seizure frequency) were not differentiated, possibly increasing the relative rate of epilepsy patients.</p><p>In line with previous observations, [<xref rid="ene70338-bib-0010" ref-type="bibr">10</xref>, <xref rid="ene70338-bib-0011" ref-type="bibr">11</xref>, <xref rid="ene70338-bib-0012" ref-type="bibr">12</xref>, <xref rid="ene70338-bib-0013" ref-type="bibr">13</xref>] only 69% of all FND cases in our study received a primary diagnostic code reflecting it unambiguously (i.e., F44 or F45). Under&#8208;recognition and misdiagnosis are commonly cited as sources of underreporting, but since our study looked at actual final diagnoses only, diagnostic coding variability might be subject to other influences. The fact that mean daily revenue is approximately 16% lower for FND cases that are coded correctly as a primary diagnosis than for cases that are coded differently or as secondary diagnoses reveals a potentially distorting incentive structure of reimbursement. This might contribute to a cycle of underreporting and neglect of patients with FND within health care services.</p><p>The generalizability of our results is chiefly limited by our monocentric study design. Bochum is part of the densely populated Ruhr Area that has a population of over 5 million and several academic neurology hospitals within its bounds, leading to regional sub&#8208;specializations of individual hospitals. This introduces imbalances in the relative frequency of specific disorders such as multiple sclerosis (likely underrepresented in our department) or epilepsy (overrepresented in our department). Furthermore, our study was conducted during the Coronavirus&#8208;Pandemic, which could potentially have affected both the incidence of FND and the likelihood for hospital admission.</p><p>In conclusion, our analysis reveals that around 5% of in&#8208;hospital neurology patients have FND, positioning it as the third most common condition after stroke and epilepsy. There is significant heterogeneity of presentations regarding age, gender, and presenting symptoms, necessitating broad training and service provision efforts. Lastly, it suggests that the previously reported inconsistency in diagnostic coding might be associated not just with diagnostic uncertainty, but with financial incentive structures that contribute to underreporting and obfuscation of the true relevance of FND.</p></sec><sec id="ene70338-sec-0016"><title>Author Contributions</title><p>
<bold>Johannes Jungilligens:</bold> methodology, formal analysis, investigation, project administration, writing &#8211; original draft. <bold>Emma Marcinkowski:</bold> methodology, formal analysis, investigation, writing &#8211; review and editing. <bold>Tim Wehner:</bold> supervision, writing &#8211; review and editing. <bold>Sabine Skodda:</bold> investigation, writing &#8211; review and editing. <bold>Stoyan Popkirov:</bold> conceptualization, methodology, supervision, project administration, writing &#8211; original draft.</p></sec><sec sec-type="COI-statement" id="ene70338-sec-0017"><title>Conflicts of Interest</title><p>S.P. receives honoraria from Springer for a book on functional neurological disorders. Sabine Skodda is currently employed by hecama LLC as a medical consultant. All other authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="ene70338-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table&#160;S1:</bold> Case data obtained for inpatients with functional neurological symptoms through in&#8208;depth review of the discharge letters.</p></caption><media xlink:href="ENE-32-e70338-s001.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="ene70338-sec-20"><title>Acknowledgements</title><p>Open Access funding enabled and organized by Projekt DEAL.</p></ack><sec sec-type="data-availability" id="ene70338-sec-0019"><title>Data Availability Statement</title><p>The individual case data is subject to strict data privacy policies and is thus not shared.</p></sec><ref-list content-type="cited-references" id="ene70338-bibl-0001"><title>References</title><ref id="ene70338-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ene70338-cit-0001"><string-name name-style="western"><given-names>M.</given-names><surname>Hallett</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Aybek</surname></string-name>, <string-name name-style="western"><given-names>B. A.</given-names><surname>Dworetzky</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>McWhirter</surname></string-name>, <string-name name-style="western"><given-names>J. P.</given-names><surname>Staab</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Stone</surname></string-name>, &#8220;<article-title>Functional Neurological Disorder: New Subtypes and Shared Mechanisms</article-title>,&#8221; <source>Lancet Neurology</source><volume>21</volume>, no. <issue>6</issue> (<year>2022</year>): <fpage>537</fpage>&#8211;<lpage>550</lpage>.<pub-id pub-id-type="pmid">35430029</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(21)00422-1</pub-id><pub-id pub-id-type="pmcid">PMC9107510</pub-id></mixed-citation></ref><ref id="ene70338-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ene70338-cit-0002"><string-name name-style="western"><given-names>A. J.</given-names><surname>Espay</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Aybek</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Carson</surname></string-name>, et&#160;al., &#8220;<article-title>Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders</article-title>,&#8221; <source>JAMA Neurology</source><volume>75</volume>, no. <issue>9</issue> (<year>2018</year>): <fpage>1132</fpage>&#8211;<lpage>1141</lpage>.<pub-id pub-id-type="pmid">29868890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2018.1264</pub-id><pub-id pub-id-type="pmcid">PMC7293766</pub-id></mixed-citation></ref><ref id="ene70338-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ene70338-cit-0003"><string-name name-style="western"><given-names>S. A.</given-names><surname>Finkelstein</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Diamond</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Carson</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Stone</surname></string-name>, &#8220;<article-title>Incidence and Prevalence of Functional Neurological Disorder: A Systematic Review</article-title>,&#8221; <source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>96</volume>, no. <issue>4</issue> (<year>2025</year>): <fpage>383</fpage>&#8211;<lpage>395</lpage>.<pub-id pub-id-type="pmid">39663114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp-2024-334767</pub-id><pub-id pub-id-type="pmcid">PMC12015090</pub-id></mixed-citation></ref><ref id="ene70338-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ene70338-cit-0004"><string-name name-style="western"><given-names>J.</given-names><surname>Stone</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Carson</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Duncan</surname></string-name>, et&#160;al., &#8220;<article-title>Who Is Referred to Neurology Clinics?&#8212;The Diagnoses Made in 3781 New Patients</article-title>,&#8221; <source>Clinical Neurology and Neurosurgery</source><volume>112</volume>, no. <issue>9</issue> (<year>2010</year>): <fpage>747</fpage>&#8211;<lpage>751</lpage>.<pub-id pub-id-type="pmid">20646830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clineuro.2010.05.011</pub-id></mixed-citation></ref><ref id="ene70338-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ene70338-cit-0005"><string-name name-style="western"><given-names>O.</given-names><surname>Ahmad</surname></string-name> and <string-name name-style="western"><given-names>K. E.</given-names><surname>Ahmad</surname></string-name>, &#8220;<article-title>Functional Neurological Disorders in Outpatient Practice: An Australian Cohort</article-title>,&#8221; <source>Journal of Clinical Neuroscience</source><volume>28</volume> (<year>2016</year>): <fpage>93</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">26754851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jocn.2015.11.020</pub-id></mixed-citation></ref><ref id="ene70338-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ene70338-cit-0006"><string-name name-style="western"><given-names>T.</given-names><surname>Lempert</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Dieterich</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Huppert</surname></string-name>, and <string-name name-style="western"><given-names>T.</given-names><surname>Brandt</surname></string-name>, &#8220;<article-title>Psychogenic Disorders in Neurology: Frequency and Clinical Spectrum</article-title>,&#8221; <source>Acta Neurologica Scandinavica</source><volume>82</volume>, no. <issue>5</issue> (<year>1990</year>): <fpage>335</fpage>&#8211;<lpage>340</lpage>.<pub-id pub-id-type="pmid">2281751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0404.1990.tb03312.x</pub-id></mixed-citation></ref><ref id="ene70338-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ene70338-cit-0007"><string-name name-style="western"><given-names>A.</given-names><surname>Pilotto</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Catania</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Mattioli</surname></string-name>, et&#160;al., &#8220;<article-title>Increased Risk of Functional Neurological Disorders Following SARS&#8208;CoV&#8208;2 Vaccination</article-title>,&#8221; <source>European Journal of Neurology</source><volume>31</volume>, no. <issue>4</issue> (<year>2024</year>): <elocation-id>e16191</elocation-id>.<pub-id pub-id-type="pmid">38165067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ene.16191</pub-id><pub-id pub-id-type="pmcid">PMC11235690</pub-id></mixed-citation></ref><ref id="ene70338-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ene70338-cit-0008"><string-name name-style="western"><given-names>T.</given-names><surname>Serranova</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>di Vico</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Tinazzi</surname></string-name>, et&#160;al., &#8220;<article-title>Functional Neurological Disorder in Europe: Regional Differences in Education and Health Policy</article-title>,&#8221; <source>European Journal of Neurology</source><volume>31</volume>, no. <issue>10</issue> (<year>2024</year>): <elocation-id>e16350</elocation-id>.<pub-id pub-id-type="pmid">39145716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ene.16350</pub-id><pub-id pub-id-type="pmcid">PMC11414792</pub-id></mixed-citation></ref><ref id="ene70338-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ene70338-cit-0009"><string-name name-style="western"><given-names>C. D.</given-names><surname>Stephen</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Fung</surname></string-name>, <string-name name-style="western"><given-names>D. L.</given-names><surname>Perez</surname></string-name>, and <string-name name-style="western"><given-names>A. J.</given-names><surname>Espay</surname></string-name>, &#8220;<article-title>Comparison of Inpatient and Emergency Department Costs to Research Funding for Functional Neurologic Disorder: An Economic Analysis</article-title>,&#8221; <source>Neurology</source><volume>104</volume>, no. <issue>9</issue> (<year>2025</year>): <elocation-id>e213632</elocation-id>.<pub-id pub-id-type="pmid">40239156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000213632</pub-id><pub-id pub-id-type="pmcid">PMC12289374</pub-id></mixed-citation></ref><ref id="ene70338-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ene70338-cit-0010"><string-name name-style="western"><given-names>L. D.</given-names><surname>Herbert</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Kim</surname></string-name>, <string-name name-style="western"><given-names>A. A.</given-names><surname>Hassan</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Wilkinson&#8208;Smith</surname></string-name>, and <string-name name-style="western"><given-names>J. L.</given-names><surname>Waugh</surname></string-name>, &#8220;<article-title>When Neurologists Diagnose Functional Neurological Disorder, Why Don't They Code for It?</article-title>,&#8221; <source>CNS Spectrums</source><volume>5</volume> (<year>2021</year>): <elocation-id>1</elocation-id>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1092852921000833</pub-id><pub-id pub-id-type="pmcid">PMC8920954</pub-id><pub-id pub-id-type="pmid">34521502</pub-id></mixed-citation></ref><ref id="ene70338-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ene70338-cit-0011"><string-name name-style="western"><given-names>H.</given-names><surname>Kholi</surname></string-name> and <string-name name-style="western"><given-names>L.</given-names><surname>Vercueil</surname></string-name>, &#8220;<article-title>Emergency Room Diagnoses of Psychogenic Nonepileptic Seizures With Psychogenic Status and Functional (Psychogenic) Symptoms: Whopping</article-title>,&#8221; <source>Epilepsy &amp; Behavior</source><volume>104</volume> (<year>2020</year>): <elocation-id>106882</elocation-id>.<pub-id pub-id-type="pmid">31982830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2019.106882</pub-id></mixed-citation></ref><ref id="ene70338-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ene70338-cit-0012"><string-name name-style="western"><given-names>A.</given-names><surname>Jones</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Smakowski</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>O'Connell</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Chalder</surname></string-name>, and <string-name name-style="western"><given-names>A. S.</given-names><surname>David</surname></string-name>, &#8220;<article-title>Functional Stroke Symptoms: A Prospective Observational Case Series</article-title>,&#8221; <source>Journal of Psychosomatic Research</source><volume>132</volume> (<year>2020</year>): <elocation-id>109972</elocation-id>.<pub-id pub-id-type="pmid">32126339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychores.2020.109972</pub-id></mixed-citation></ref><ref id="ene70338-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ene70338-cit-0013"><string-name name-style="western"><given-names>D.</given-names><surname>Petrie</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Lehn</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Barratt</surname></string-name>, et&#160;al., &#8220;<article-title>How Is Functional Neurological Disorder Managed in Australian Hospitals? A Multi&#8208;Site Study Conducted on Acute Inpatient and Inpatient Rehabilitation Wards</article-title>,&#8221; <source>Movement Disorders Clinical Practice</source><volume>10</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>774</fpage>&#8211;<lpage>782</lpage>.<pub-id pub-id-type="pmid">37205237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mdc3.13718</pub-id><pub-id pub-id-type="pmcid">PMC10187007</pub-id></mixed-citation></ref><ref id="ene70338-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="ene70338-cit-0014"><collab collab-type="authors">jamovi</collab>
, <article-title>The Jamovi Project. Version 2.6 ed2024</article-title>.</mixed-citation></ref><ref id="ene70338-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="ene70338-cit-0015"><collab collab-type="authors">R: A Language and Environment for Statistical Computing</collab>
, <article-title>Version 4.4 ed: R Core Team 2024</article-title>.</mixed-citation></ref><ref id="ene70338-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ene70338-cit-0016"><string-name name-style="western"><given-names>S.</given-names><surname>Gargalas</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Weeks</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Khan&#8208;Bourne</surname></string-name>, et&#160;al., &#8220;<article-title>Incidence and Outcome of Functional Stroke Mimics Admitted to a Hyperacute Stroke Unit</article-title>,&#8221; <source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>88</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>2</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">26319438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp-2015-311114</pub-id></mixed-citation></ref><ref id="ene70338-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ene70338-cit-0017"><string-name name-style="western"><given-names>S. S.</given-names><surname>Wilkins</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Bourke</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Salam</surname></string-name>, et&#160;al., &#8220;<article-title>Functional Stroke Mimics: Incidence and Characteristics at a Primary Stroke Center in the Middle East</article-title>,&#8221; <source>Psychosomatic Medicine</source><volume>80</volume>, no. <issue>5</issue> (<year>2018</year>): <fpage>416</fpage>&#8211;<lpage>421</lpage>.<pub-id pub-id-type="pmid">29394187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PSY.0000000000000563</pub-id><pub-id pub-id-type="pmcid">PMC5991183</pub-id></mixed-citation></ref><ref id="ene70338-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ene70338-cit-0018"><string-name name-style="western"><given-names>S.</given-names><surname>Popkirov</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Stone</surname></string-name>, and <string-name name-style="western"><given-names>A. M.</given-names><surname>Buchan</surname></string-name>, &#8220;<article-title>Functional Neurological Disorder: A Common and Treatable Stroke Mimic</article-title>,&#8221; <source>Stroke</source><volume>51</volume>, no. <issue>5</issue> (<year>2020</year>): <fpage>1629</fpage>&#8211;<lpage>1635</lpage>.<pub-id pub-id-type="pmid">32295508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.029076</pub-id></mixed-citation></ref><ref id="ene70338-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ene70338-cit-0019"><string-name name-style="western"><given-names>O.</given-names><surname>Cengiz</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Jungilligens</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Michaelis</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Wellmer</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Popkirov</surname></string-name>, &#8220;<article-title>Dissociative Seizures in the Emergency Room: Room for Improvement</article-title>,&#8221; <source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>95</volume>, no. <issue>4</issue> (<year>2024</year>): <fpage>294</fpage>&#8211;<lpage>299</lpage>.<pub-id pub-id-type="pmid">37758452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp-2023-332063</pub-id><pub-id pub-id-type="pmcid">PMC10958294</pub-id></mixed-citation></ref><ref id="ene70338-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ene70338-cit-0020"><string-name name-style="western"><given-names>S.</given-names><surname>Popkirov</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Jungilligens</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Gronheit</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Wellmer</surname></string-name>, &#8220;<article-title>Diagnosing Psychogenic Nonepileptic Seizures: Video&#8208;EEG Monitoring, Suggestive Seizure Induction and Diagnostic Certainty</article-title>,&#8221; <source>Epilepsy &amp; Behavior</source><volume>73</volume> (<year>2017</year>): <fpage>54</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">28622545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2017.05.027</pub-id></mixed-citation></ref><ref id="ene70338-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ene70338-cit-0021"><string-name name-style="western"><given-names>K.</given-names><surname>Walther</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Volbers</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Erdmann</surname></string-name>, et&#160;al., &#8220;<article-title>Psychological Long&#8208;Term Outcome in Patients With Psychogenic Nonepileptic Seizures</article-title>,&#8221; <source>Epilepsia</source><volume>60</volume>, no. <issue>4</issue> (<year>2019</year>): <fpage>669</fpage>&#8211;<lpage>678</lpage>.<pub-id pub-id-type="pmid">30838655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.14682</pub-id></mixed-citation></ref><ref id="ene70338-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ene70338-cit-0022"><string-name name-style="western"><given-names>A.</given-names><surname>Lehn</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Watson</surname></string-name>, <string-name name-style="western"><given-names>E. G.</given-names><surname>Ryan</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Jones</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Cheah</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Dionisio</surname></string-name>, &#8220;<article-title>Psychogenic Nonepileptic Seizures Treated as Epileptic Seizures in the Emergency Department</article-title>,&#8221; <source>Epilepsia</source><volume>62</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>2416</fpage>&#8211;<lpage>2425</lpage>.<pub-id pub-id-type="pmid">34396517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.17038</pub-id></mixed-citation></ref><ref id="ene70338-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ene70338-cit-0023"><string-name name-style="western"><given-names>J. M.</given-names><surname>Dickson</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Dudhill</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Shewan</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Mason</surname></string-name>, <string-name name-style="western"><given-names>R. A.</given-names><surname>Grunewald</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Reuber</surname></string-name>, &#8220;<article-title>Cross&#8208;Sectional Study of the Hospital Management of Adult Patients With a Suspected Seizure (EPIC2)</article-title>,&#8221; <source>BMJ Open</source><volume>7</volume>, no. <issue>7</issue> (<year>2017</year>): <elocation-id>e015696</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2016-015696</pub-id><pub-id pub-id-type="pmcid">PMC5541576</pub-id><pub-id pub-id-type="pmid">28706099</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>